Source: https://profiles.bu.edu/Vincent.Falanga
Timestamp: 2019-04-24 06:16:21+00:00

Document:
A dedicated researcher, clinician, and educator, Dr. Vincent Falanga has had a longstanding relationship with the Boston University community. For the past 15 years, Dr. Falanga has been a Professor of Dermatology and Biochemistry at the Boston University School of Medicine (BUSM). In addition, he served as the Assistant Dean of Clinical and Faculty Affairs, as well as the Director of the Boston University Medical Students Ambulatory Medical Clerkship at Roger Williams Medical Center (RWMC), a research and clinical affiliate of the BUSM. From 1998 to 2013, he was the Chairman and Program Director of the Department of Dermatology at RWMC. Prior to that, Dr. Falanga held several academic appointments, including an initial one at the University of Pittsburgh School Of Medicine, and then as Professor of Dermatology and Medicine at the Miller School of Medicine at the University of Miami. A graduate of Harvard Medical School, Dr. Falanga received training in Internal Medicine and Dermatology at the University of Miami and the University of Pennsylvania, respectively. He is Board certified in both Medicine and Dermatology. In 2004, he was the President of the Wound Healing Society, the premier research organization in the world dedicated to wound healing.
Vincent Falanga’s remarkable research career began in the fields of molecular and cell biology, evolving over the years to groundbreaking human-based translational research. He made seminal contributions to the expansion and growth of single cells in low oxygen tension and to the effects and transcriptional regulation of transforming growth factor-ß 1 (TGF-ß1). Dr. Falanga later focused his efforts on human recombinant growth factors and was the first to use a recombinant growth factor (EGF) in human non-healing wounds. He showed that systemic anabolic steroids can heal the painful skin ulcers due to cryofibrinogenemia and that doubling the dose of systemically administered pentoxifylline will heal venous ulcers. In 1998, he was the lead author in the use of living bioengineered skin in non-healing wounds, which led to the first ever FDA approval of bioengineered skin for accelerating wound closure. In 2007, he was the first to successfully use autologous cultured bone marrow-derived mesenchymal stem cells in human chronic wounds. In his new role as the Department of Dermatology’s Vice Chair for Research, Dr. Falanga will spearhead and coordinate many of the research projects related to tissue injury, repair processes, and regeneration. The School of Medicine and the Department of Dermatology are currently building a Good Manufacturing Practice (GMP) facility in which Dr. Falanga will oversee the research and development of novel treatments utilizing the therapeutic potential of stem cells in the care of chronic wounds caused by disorders ranging from diabetes to autoimmune disease. The GMP facility promises to enrich the translational capabilities of the Medical Center in Dermatology and other specialties. His current project with stem cells in human wounds is funded by the National Institutes of Health, which has awarded Dr. Falanga more than $45 million over the course of his career.
Grada A, Mervis J, Falanga V. Research Techniques Made Simple: Animal Models of Wound Healing. J Invest Dermatol. 2018 Oct; 138(10):2095-2105.e1.View Related Profiles.
Ferrer-Sola M, Sureda-Vidal H, Altimiras-Roset J, Fontsere-Candell E, Gonzalez-Martinez V, Espaulella-Panicot J, Falanga V, Otero-Viñas M. Hydrosurgery as a safe and efficient debridement method in a clinical wound unit. J Wound Care. 2017 Oct 02; 26(10):593-599. PMID: 28976826.
Grada A, Falanga V. Cryofibrinogenemia-Induced Cutaneous Ulcers: A Review and Diagnostic Criteria. Am J Clin Dermatol. 2017 Feb; 18(1):97-104.View Related Profiles.
Grada A, Otero-Vinas M, Prieto-Castrillo F, Obagi Z, Falanga V. Research Techniques Made Simple: Analysis of Collective Cell Migration Using the Wound Healing Assay. J Invest Dermatol. 2017 Feb; 137(2):e11-e16.View Related Profiles.
Grada A, Falanga V. Novel Stem Cell Therapies for Applications to Wound Healing and Tissue Repair. Surg Technol Int. 2016 Oct 26; 29:29-37.View Related Profiles.
Alani RM, Larson A, Falanga V. Paving a New Path Towards Academic Medicine-A Novel Approach to Graduate Medical Education in the United States. Acad Med. 2016 08; 91(8):1039-40.View Related Profiles.
Mani R, Margolis DJ, Shukla V, Akita S, Lazarides M, Piaggesi A, Falanga V, Teot L, Xie T, Bing FX, Romanelli M, Attinger C, Han CM, Lu S, Meaume S, Xu Z, Viswanathan V. Optimizing Technology Use for Chronic Lower-Extremity Wound Healing: A Consensus Document. Int J Low Extrem Wounds. 2016 Jun; 15(2):102-19. PMID: 27207900; DOI: 10.1177/1534734616646261;.
Fournier JB, Dabiri G, Thomas V, Skowron G, Carson P, Falanga V. Serratia marcescens Bullous Cellulitis in a Splenectomized Patient: A Case Report and Review of the Literature. Int J Low Extrem Wounds. 2016 Jun; 15(2):161-8.View Related Profiles.
Otero-Viñas M, Falanga V. Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy. Adv Wound Care (New Rochelle). 2016 Apr 01; 5(4):149-163. PMID: 27076993.
Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-ß) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016 Mar; 24(2):215-22.View Related Profiles.
Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney JA, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. J Am Geriatr Soc. 2015 Mar; 63(3):427-38. PMID: 25753048; PMCID: PMC4582412; DOI: 10.1111/jgs.13332;.
Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, DiPietro L, Falanga V, Fife C, Gardner S, Grice E, Harmon J, Hazzard WR, High KP, Houghton P, Jacobson N, Kirsner RS, Kovacs EJ, Margolis D, McFarland Horne F, Reed MJ, Sullivan DH, Thom S, Tomic-Canic M, Walston J, Whitney J, Williams J, Zieman S, Schmader K. Chronic wound repair and healing in older adults: current status and future research. Wound Repair Regen. 2015 Jan-Feb; 23(1):1-13. PMID: 25486905; PMCID: PMC4414710; DOI: 10.1111/wrr.12245;.
Carson P, Hong CJ, Otero-Vinas M, Arsenault EF, Falanga V. Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, double-blinded, placebo-controlled trial. Int J Low Extrem Wounds. 2015 Mar; 14(1):11-8.View Related Profiles.
Lin X, Kwak T, Fiore D, Thompson PJ, Goodrich JK, Yufit T, Michalowski AM, Deschenes J, Carson P, Otero-Vinas M, Falanga V. An in vitro priming step increases the expression of numerous epidermal growth and migration mediators in a tissue-engineering construct. J Tissue Eng Regen Med. 2017 Mar; 11(3):713-723.View Related Profiles.
Chorzalska A, Salloum I, Shafqat H, Khan S, Marjon P, Treaba D, Schorl C, Morgan J, Bryke CR, Falanga V, Zhao TC, Reagan J, Winer E, Olszewski AJ, Al-Homsi AS, Kouttab N, Dubielecka PM. Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. Leukemia. 2014 Nov; 28(11):2165-77.View Related Profiles.
PMID: 24699303; PMCID: PMC4185277; DOI: 10.1038/leu.2014.120;.
Yufit T, Carson P, Falanga V. Topical delivery of cultured stem cells to human non-healing wounds: GMP facility development in an academic setting and FDA requirements for an IND and human testing. Curr Drug Deliv. 2014; 11(5):572-81.View Related Profiles.
Dabiri G, Hammerman S, Carson P, Falanga V. Low-grade elastic compression regimen for venous leg ulcers--an effective compromise for patients requiring daily dressing changes. Int Wound J. 2015 Dec; 12(6):655-61.View Related Profiles.
PMID: 24267477; PMCID: PMC4032807; DOI: 10.1111/iwj.12186;.
Iwamoto S, Lin X, Ramirez R, Carson P, Fiore D, Goodrich J, Yufit T, Falanga V. Bone marrow cell mobilization by the systemic use of granulocyte colony-stimulating factor (GCSF) improves wound bed preparation. Int J Low Extrem Wounds. 2013 Dec; 12(4):256-64.View Related Profiles.
Dabiri G, Heiner D, Falanga V. The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds. Expert Opin Emerg Drugs. 2013 Dec; 18(4):405-19. PMID: 24004161; DOI: 10.1517/14728214.2013.833184;.
Licata LA, Nguyen CT, Burga RA, Falanga V, Espat NJ, Ayala A, Thorn M, Junghans RP, Katz SC. Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol. 2013 Oct; 94(4):813-23. PMID: 23883516; PMCID: PMC3774842; DOI: 10.1189/jlb.0313137;.
Dabiri G, Falanga V. Connective tissue ulcers. J Tissue Viability. 2013 Nov; 22(4):92-102. PMID: 23756459; PMCID: PMC3930159; DOI: 10.1016/j.jtv.2013.04.003;.
Falanga V, Shen J. Growth Factors. Cutaneous Wound Healing. V Falanga editor. Martin Dunitz Publishers. London. 2013.
Anderson-Dockter H, Clark T, Iwamoto S, Lu M, Fiore D, Falanga JK, Falanga V. Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins. Dermatol Surg. 2012 Aug; 38(8):1357-66.View Related Profiles.
PMID: 22691048; PMCID: PMC3412942; DOI: 10.1111/j.1524-4725.2012.02417.x;.
Falanga V. Stem cells in tissue repair and regeneration. J Invest Dermatol. 2012 Jun; 132(6):1538-41. PMID: 22584501; DOI: 10.1038/jid.2012.77;.
Kurniali PC, O'Gara K, Wang X, Wang LJ, Somasundar P, Falanga V, Espat NJ, Katz SC. The effects of sorafenib on liver regeneration in a model of partial hepatectomy. J Surg Res. 2012 Nov; 178(1):242-7. PMID: 22482755; PMCID: PMC3419806; DOI: 10.1016/j.jss.2012.01.033;.
Falanga V, Lindholm C, Carson P, Panuncialman J, Mamakos L, Lotti T, Falanga J. Text Atlas of Wound Healing. Informa Healthcare. 2012.
Falanga V, Iwamoto A. Preparation of the wound bed of the diabetic foot ulcer. The Diabetic Foot. Eds. Aris Veves, John M. Giurini, Fank W. LoGerfo. Human Press. 3rd Edition. Totowa, NJ. 2012.
Falanga V, Iwamoto S. Wound repair: Mechanisms and practical considerations. Fitspatrick’s Dermatology in General Medicine. Eds. Wolff K, Goldsmith LS, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Elsevier. 8th Edition. 2012.
Luo S, Yufit T, Carson P, Fiore D, Falanga J, Lin X, Mamakos L, Falanga V. Differential keratin expression during epiboly in a wound model of bioengineered skin and in human chronic wounds. Int J Low Extrem Wounds. 2011 Sep; 10(3):122-9.View Related Profiles.
Lazic T, Falanga V. Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg. 2011 Jan; 127 Suppl 1:75S-90S. PMID: 21200276; DOI: 10.1097/PRS.0b013e3182009d9f;.
Panuncialman J, Falanga V. Unusual causes of cutaneous ulceration. Surg Clin North Am. 2010 Dec; 90(6):1161-80. PMID: 21074034; PMCID: PMC2991050; DOI: 10.1016/j.suc.2010.08.006;.
Gillespie DL, Kistner B, Glass C, Bailey B, Chopra A, Ennis B, Marston B, Masuda E, Moneta G, Nelzen O, Raffetto J, Raju S, Vedantham S, Wright D, Falanga V. Venous ulcer diagnosis, treatment, and prevention of recurrences. J Vasc Surg. 2010 Nov; 52(5 Suppl):8S-14S. PMID: 20678885; DOI: 10.1016/j.jvs.2010.05.068;.
Li L, Iwamoto S, Jisun Cha, Falanga V. Diabetic foot ulcer calluses show histological similarities to HPV infection without evidence of HPV involvement by nested PCR. Int J Low Extrem Wounds. 2010 Jun; 9(2):84-9.View Related Profiles.
Panuncialman J, Hammerman S, Carson P, Falanga V. Wound edge biopsy sites in chronic wounds heal rapidly and do not result in delayed overall healing of the wounds. Wound Repair Regen. 2010 Jan-Feb; 18(1):21-5. PMID: 20082677; PMCID: PMC3013292; DOI: 10.1111/j.1524-475X.2009.00559.x;.
Panuncialman J, Falanga V. The science of wound bed preparation. Surg Clin North Am. 2009 Jun; 89(3):611-26. PMID: 19465200; DOI: 10.1016/j.suc.2009.03.009;.
Iwamoto S, Iwamoto AT, Cha J, Clark T, Lu M, Breen C, Bhawan J, Falanga V. The utility of the DNA microarray scanner to simplify the immunofluorescence evaluation of autoimmune bullous diseases. Am J Dermatopathol. 2009 May; 31(3):218-22.View Related Profiles.
PMID: 19384060; PMCID: PMC2756582; DOI: 10.1097/DAD.0b013e31818ffde1;.
Falanga V. Bone marrow cells can manipulate healing. Blood. 2009 Jan 29; 113(5):982-3. PMID: 19179473; PMCID: PMC2635088; DOI: 10.1182/blood-2008-12-189712;.
Chartier M, Falanga V. Healing of ulcers due to cryofibrinogenemia with colchicine and high-dose pentoxifylline. Am J Clin Dermatol. 2009; 10(1):39-42. PMID: 19170411; DOI: 10.2165/0128071-200910010-00007;.
Panuncialman J, Falanga V. Venous leg ulcers. Conn’s Current Therapy. Elsevier. 2009; 855-857.
McClain SE, Goldenberg G, Falanga V, Jorizzo JL. Scleroderma, Raynaud’s Phenomenon, and Related Conditions. Dermatological Signs of Internal Disease. Edited by Jeffrey P. Callen, Joseph L. Jorizzo, Jean L. Bolognia, Warren W. Piette, John J. Zone. Saunders Elsevier. 2009; 21-29.
Massé M, Falanga V, Zhou LH. Use of topical povidone-iodine resulting in an iododerma-like eruption. J Dermatol. 2008 Nov; 35(11):744-7. PMID: 19120771; DOI: 10.1111/j.1346-8138.2008.00554.x;.
Falanga V, Brem H, Ennis WJ, Wolcott R, Gould LJ, Ayello EA. Maintenance debridement in the treatment of difficult-to-heal chronic wounds. Recommendations of an expert panel. Ostomy Wound Manage. 2008 Jun; Suppl:2-13; quiz 14-5. PMID: 18980069.
Falanga V, Chartier M, Butmarc J, Tibbetts L. Collision of desmoplastic-neurotropic melanoma and squamous cell carcinoma on the lip. J Cutan Pathol. 2008 May; 35(5):473-6. PMID: 18399808; DOI: 10.1111/j.1600-0560.2007.00829.x;.
Falanga V. Measurements in wound healing. Int J Low Extrem Wounds. 2008 Mar; 7(1):9-11. PMID: 18372262; DOI: 10.1177/1534734608314570;.
Falanga V, Iwamoto S. Wound repair: Mechanisms and practical considerations. Fitzpatrick’s Dermatology in General Medicine. Eds. Wolff K, Goldmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. McGraw Hill,7th Edition. New York, NY. 2008; 2342-2349.
Falanga V, Killoran CE. Morphea. Fitzpatrick’s Dermatology in General Medicine. Eds. Wolff K, Goldmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. McGraw Hill,7th Edition. New York, NY. 2008; 543-546.
Cha J, Falanga V. Transforming growth factor-ß in cutaneous tissue repair. Transforming Growth Factor-ß in Cancer Therapy. Ed. Sonia B. Jakowlew. Humana Press. 2008; 675-691.
Cha J, Kwak T, Butmarc J, Kim TA, Yufit T, Carson P, Kim SJ, Falanga V. Fibroblasts from non-healing human chronic wounds show decreased expression of beta ig-h3, a TGF-beta inducible protein. J Dermatol Sci. 2008 Apr; 50(1):15-23.View Related Profiles.
Panuncialman J, Falanga V. The science of wound bed preparation. Clin Plast Surg. 2007 Oct; 34(4):621-32. PMID: 17967618.
Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, Shrayer D, Carson P. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007 Jun; 13(6):1299-312.View Related Profiles.
Ingraffea A, Donohue K, Wilkel C, Falanga V. Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh. J Am Acad Dermatol. 2007 May; 56(5 Suppl):S124-6. PMID: 17434040.
Falanga V, Butmarc J, Cha J, Yufit T, Carson P. Migration of the epidermal over the dermal component (epiboly) in a bilayered bioengineered skin construct. Tissue Eng. 2007 Jan; 13(1):21-8.View Related Profiles.
Cha J, Falanga V. Stem cells in cutaneous wound healing. Clin Dermatol. 2007 Jan-Feb; 25(1):73-8. PMID: 17276204.
Falanga V, Faria K. Bioengineered skin constructs. Principles of Tissue Engineering. 3rd Edition. Editors: Robert Lanza, Robert Langer, Joseph P. Vacanti. Elsevier. New York, NY. 2007; 1167-1186.
Sibbald GR, Williamson D, Contreras-Ruiz J, Burrows C, Despalis M, Falanga V, Cherry GW. Chronic Wound Care, 4th Edition, editors Krasner DL, Rodeheaver GT, Sibbald GR, chapter 44. HMP Communication. Malvern, PA. 2007; 429-442.
Panuncialman J, Falanga V. Basic approach to inflammatory ulcers. Dermatol Ther. 2006 Nov-Dec; 19(6):365-76. PMID: 17199679.
Falanga V, Saap LJ, Ozonoff A. Wound bed score and its correlation with healing of chronic wounds. Dermatol Ther. 2006 Nov-Dec; 19(6):383-90. PMID: 17199681.
Kissin EY, Schiller AM, Gelbard RB, Anderson JJ, Falanga V, Simms RW, Korn JH, Merkel PA. Durometry for the assessment of skin disease in systemic sclerosis. Arthritis Rheum. 2006 Aug 15; 55(4):603-9.View Related Profiles.
Hu S, Kirsner RS, Falanga V, Phillips T, Eaglstein WH. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study. Wound Repair Regen. 2006 Jul-Aug; 14(4):427-33.View Related Profiles.
Cavorsi J, Vicari F, Wirthlin DJ, Ennis W, Kirsner R, O'Connell SM, Steinberg J, Falanga V. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Wound Repair Regen. 2006 Mar-Apr; 14(2):102-9. PMID: 16630097.
Falanga V. Pressure ulcers and wound bed preparation. Science and Practice of Pressure Ulcer Management, ed. Marco Romanelli. Springer-Verlag. London. 2006; 99-109.
Falanga V. Preparation of the wound bed of the diabetic foot ulcer. The Diabetic Foot. Eds. Aris Veves, John M. Giurini, Fank W. LoGerfo. 2nd Edition,Human Press. Totowa, NJ. 2006; 299-310.
Falanga V (ed.). Wound Healing. Dermatologic Therapy. Blackwell Publishing. Oxford, UK. 2006; 19.
Nori S, Greene MA, Schrager HM, Falanga V. Infectious occupational exposures in dermatology--a review of risks and prevention measures. I. For all dermatologists. J Am Acad Dermatol. 2005 Dec; 53(6):1010-9. PMID: 16310062.
Nori S, Greene MA, Schrager HM, Falanga V. Infectious occupational exposures in dermatology--a review of risks and prevention measures. II. The pregnant dermatologist. J Am Acad Dermatol. 2005 Dec; 53(6):1020-6. PMID: 16310063.
Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005 Nov 12; 366(9498):1736-43. PMID: 16291068.
Donohue KG, Carson P, Iriondo M, Zhou L, Saap L, Gibson K, Falanga V. Safety and efficacy of a bilayered skin construct in full-thickness surgical wounds. J Dermatol. 2005 Aug; 32(8):626-31.View Related Profiles.
Massé M, Cserhalmi-Friedman PB, Falanga V, Celebi JT, Martinez-Mir A, Christiano AM. Identification of novel type VII collagen gene mutations resulting in severe recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol. 2005 May; 30(3):289-93. PMID: 15807692.
Donohue KG, Falanga V. Skin substitutes in acute and chronic wounds. Manual of Wound Management and Heaing. Ed. Bok Lee. McGraw-Hill. New York, NY. 2005; 298-308.
Saap L, Fahim S, Arsenault E, Pratt M, Pierscianowski T, Falanga V, Pedvis-Leftick A. Contact sensitivity in patients with leg ulcerations: a North American study. Arch Dermatol. 2004 Oct; 140(10):1241-6. PMID: 15492187.
Saap LJ, Donohue K, Falanga V. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers. Dermatol Surg. 2004 Aug; 30(8):1095-100. PMID: 15274699.
Nahm WK, Philpot BD, Adams MM, Badiavas EV, Zhou LH, Butmarc J, Bear MF, Falanga V. Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol. 2004 Aug; 200(2):309-17. PMID: 15174101.
Butmarc J, Yufit T, Carson P, Falanga V. Human beta-defensin-2 expression is increased in chronic wounds. Wound Repair Regen. 2004 Jul-Aug; 12(4):439-43.View Related Profiles.
Brem H, Kirsner RS, Falanga V. Protocol for the successful treatment of venous ulcers. Am J Surg. 2004 Jul; 188(1A Suppl):1-8. PMID: 15223495.
Falanga V, Schrayer D, Cha J, Butmarc J, Carson P, Roberts AB, Kim SJ. Full-thickness wounding of the mouse tail as a model for delayed wound healing: accelerated wound closure in Smad3 knock-out mice. Wound Repair Regen. 2004 May-Jun; 12(3):320-6. PMID: 15225210.
Ayello EA, Dowsett C, Schultz GS, Sibbald RG, Falanga V, Harding K, Romanelli M, Stacey M, TEot L, Vanscheidt W. TIME heals all wounds. Nursing. 2004 Apr; 34(4):36-41; quiz, 41-2. PMID: 15247672.
Eberting CL, Shrayer DP, Butmarc J, Falanga V. Histologic progression of B16 F10 metastatic melanoma in C57BL/6 mice over a six week time period: distant metastases before local growth. J Dermatol. 2004 Apr; 31(4):299-304. PMID: 15187325.
Falanga V. The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):88-94. PMID: 14757419.
Donohue KG, Saap L, Falanga V. Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations. J Eur Acad Dermatol Venereol. 2003 Sep; 17(5):504-11. PMID: 12941082.
Quesenberry PJ, Colvin GA, Abedi M, Lambert JF, Moore B, Demers D, Greer D, McAuliffe C, Dooner M, Lum LG, Badiavas E, Falanga V. The marrow stem cell: the continuum. Bone Marrow Transplant. 2003 Aug; 32 Suppl 1:S19-22. PMID: 12931234.
Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 2003 Aug; 196(2):245-50. PMID: 12811816.
Paquette DL, Falanga V. Cutaneous concerns of scleroderma patients. J Dermatol. 2003 Jun; 30(6):438-43. PMID: 12810990.
Kim BC, Kim HT, Park SH, Cha JS, Yufit T, Kim SJ, Falanga V. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression. J Cell Physiol. 2003 Jun; 195(3):331-6.View Related Profiles.
Quesenberry P, Colvin G, Lambert JF, Abedi M, Cerny J, Dooner M, Moore B, McAuliffe C, Demers D, Greer D, Parent A, Badiavas E, Lum L, Falanga V. Marrow stem cell potential within a continuum. Ann N Y Acad Sci. 2003 May; 996:209-21. PMID: 12799298.
Shen JT, Falanga V. Innovative therapies in wound healing. J Cutan Med Surg. 2003 May-Jun; 7(3):217-24. PMID: 12704530.
Falanga V. Wound bed preparation: future approaches. Ostomy Wound Manage. 2003 May; 49(5A Suppl):30-3. PMID: 12883163.
Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol. 2003 Apr; 139(4):510-6. PMID: 12707099.
Nahm WK, Donohue KG, Danahy JF, Badiavas E, Falanga V. Systemic 5-fluorouracil producing an inflammatory response in porokeratosis. J Eur Acad Dermatol Venereol. 2003 Mar; 17(2):190-2. PMID: 12705749.
Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, Romanelli M, Stacey MC, Teot L, Vanscheidt W. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003 Mar; 11 Suppl 1:S1-28. PMID: 12654015.
Shen JT, Falanga V. Growth factors, signal transduction, and cellular responses. J Dermatol. 2003 Jan; 30(1):5-16. PMID: 12598704.
Falanga V. Systemic sclerosis (scleroderma). Dermatology. Eds. Bolognia JL, Jorizzo JL, Rapini RP. Mosby/Elsevier. Philadelphia, PA. 2003; 625-632.
Falanga V, Jorizzo JL. Scleroderma, Raynaud’s phenomenon, and related conditions. Dermatologcial Signs of Internal Disease, editors Callen JP, Jorizzo JL, Bolognia JL, Piette WW, Zone JJ. W.B. Saunders. Philadelphia, PA. 2003; 17-23.
Falanga V. Mechanisms of cutaneous wound repair. Fitzpatrick’s Dermatology in General Medicine, eds. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Sixth Edition. McGraw-Hill. New York, NY. 2003; 236-246.
Falanga V (ed.). New Concepts in Wound Bed Preparation. Springer-Verlag GmbH & Co. KG. New York. 2003.
Quesenberry PJ, Lambert JF, Colvin GA, Dooner M, McAuliffe CI, Abedi M, Greer D, Demers D, Cerny J, Moore BE, Badiavas E, Falanga V. The stem cell continuum: A plastic plasticity. Stem Cell Therapy for Autoimmune Disease, ed. Richard K. Burt. Landes Bioscience/Eurekah.com. 2003; 91-94.
Saap LJ, Falanga V. Debridement performance index and its correlation with complete closure of diabetic foot ulcers. Wound Repair Regen. 2002 Nov-Dec; 10(6):354-9. PMID: 12453138.
Falanga V, Isaacs C, Paquette D, Downing G, Kouttab N, Butmarc J, Badiavas E, Hardin-Young J. Wounding of bioengineered skin: cellular and molecular aspects after injury. J Invest Dermatol. 2002 Sep; 119(3):653-60. PMID: 12230509.
Stacey M, Falanga V, Marston W, Moffat C, Phillips T, Sibbald RG, Vanscheidt W, Lindholm C. Compression therapy in the treatment of venous leg ulcers. Nurs Times. 2002 Sep 3-9; 98(36):39-43.View Related Profiles.
Phillips TJ, Manzoor J, Rojas A, Isaacs C, Carson P, Sabolinski M, Young J, Falanga V. The longevity of a bilayered skin substitute after application to venous ulcers. Arch Dermatol. 2002 Aug; 138(8):1079-81.View Related Profiles.
Nahm WK, Badiavas E, Touma DJ, Wilkel CS, Falanga V. Calciphylaxis with peau d'orange induration and absence of classical features of purpura, livedo reticularis and ulcers. J Dermatol. 2002 Apr; 29(4):209-13. PMID: 12027085.
Falanga V, Zhou L, Yufit T. Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1. J Cell Physiol. 2002 Apr; 191(1):42-50.View Related Profiles.
Badiavas EV, Paquette D, Carson P, Falanga V. Human chronic wounds treated with bioengineered skin: histologic evidence of host-graft interactions. J Am Acad Dermatol. 2002 Apr; 46(4):524-30.View Related Profiles.
Zhou LH, Nahm WK, Badiavas E, Yufit T, Falanga V. Slow release iodine preparation and wound healing: in vitro effects consistent with lack of in vivo toxicity in human chronic wounds. Br J Dermatol. 2002 Mar; 146(3):365-74.View Related Profiles.
Paquette D, Falanga V. Leg ulcers. Clin Geriatr Med. 2002 Feb; 18(1):77-88, vi. PMID: 11913740.
Nahm WK, Zhou L, Falanga V. Sustained ability for fibroblast outgrowth from stored neonatal foreskin: a model for studying mechanisms of fibroblast outgrowth. J Dermatol Sci. 2002 Feb; 28(2):152-8. PMID: 11858954.
Quesenberry PJ, Colvin GA, Lambert JF, Frimberger AE, Dooner MS, Mcauliffe CI, Miller C, Becker P, Badiavas E, Falanga VJ, Elfenbein G, Lum LG. The new stem cell biology. Trans Am Clin Climatol Assoc. 2002; 113:182-206; discussion 206-7. PMID: 12053709; PMCID: PMC2194475.
Nahm WK, Tsoukas MM, Falanga V, Carson PA, Sami N, Touma DJ. Preliminary study of fine changes in the duration of dynamic cooling during 755-nm laser hair removal on pain and epidermal damage in patients with skin types III-V. Lasers Surg Med. 2002; 31(4):247-51.View Related Profiles.
Paquette D, Falanga V. Leg Ulcers. Clinics in Geriatric Medicine, Geriatric Dermatology, Part II. Ed. Barbara A. Gilchrest. W.B. Saunders. Philadelphia, PA. 2002; 77-88.
Falanga V. Physiology and Pathophysiology of Wound Healing. Diabetic Foot: Medical and Surgical Treatment. Editors Veves A, Giurini J, LoGerfo F. Humana Press. Totowa, NJ. 2002; 59-73.
Falanga V, Harding K (eds.). The Clinical Relevance of Wound Bed Preparation. Springer-Verlag GmbH & Co. KG. New York. 2002.
Romanelli M, Falanga V. Hardware and Measuring Principles: The Durometer. Bioengineering of the Skin. Skin Biomechanics. Eds. Peter Elsner, Enzo Berardesca, Klaus-P Wilhelm, Howard I. Maybach. CRC Press. New York, New York. 2002; 139-145.
Brem H, Balledux J, Sukkarieh T, Carson P, Falanga V. Healing of venous ulcers of long duration with a bilayered living skin substitute: results from a general surgery and dermatology department. Dermatol Surg. 2001 Nov; 27(11):915-9. PMID: 11737123.
Robson MC, Phillips TJ, Falanga V, Odenheimer DJ, Parish LC, Jensen JL, Steed DL. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen. 2001 Sep-Oct; 9(5):347-52.View Related Profiles.
Paquette D, Badiavas E, Falanga V. Short-contact topical tretinoin therapy to stimulate granulation tissue in chronic wounds. J Am Acad Dermatol. 2001 Sep; 45(3):382-6. PMID: 11511834.
Badiavas EV, Zhou L, Falanga V. Growth inhibition of primary keratinocytes following transduction with a novel TGFbeta-1 containing retrovirus. J Dermatol Sci. 2001 Sep; 27(1):1-6. PMID: 11457637.
Falanga V. The dark side of evidence-based wound management. J Wound Care. 2001 May; 10(5):145. PMID: 12964319.
Badiavas EV, Falanga V. Gene therapy. J Dermatol. 2001 Apr; 28(4):175-92. PMID: 11449669.
Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001 Feb; 24(2):290-5. PMID: 11213881.
de Imus G, Golomb C, Wilkel C, Tsoukas M, Nowak M, Falanga V. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol. 2001 Jan; 44(1):61-6. PMID: 11148478.
Sibbald GR, Williamson D, Falanga V, Cherry GW. Venous Leg Ulcers. Chronic Wound Care. Eds. Krasner DL, Rodeheaver GT, Sibbald GR. HMP Communications. Wayne, PA. 2001; 483-494.
de Imus FA Abigail, Falanga V. Advances in the Local Treatment of Venous Ulcers Using Bioengineered Skin. Handbook of Venus Disorders: Guidelines of the American Venous Forum. Eds. Gloviczki P, Yao JST. Parmenter Publishing Services. Evanston, IL. 2001; 322-328.
Falanga V (ed.). Cutaneous Wound Healing. Martin Dunitz Publishers. London. 2001.
Yamaguchi Y, Crane S, Zhou L, Ochoa SM, Falanga V. Lack of co-ordinate expression of the alpha1(I) and alpha1(III) procollagen genes in fibroblast clonal cultures. Br J Dermatol. 2000 Dec; 143(6):1149-53.View Related Profiles.
Phillips TJ, Machado F, Trout R, Porter J, Olin J, Falanga V. Prognostic indicators in venous ulcers. J Am Acad Dermatol. 2000 Oct; 43(4):627-30.View Related Profiles.
Shen JT, Falanga V. Treatment of Venous Ulcers Using a Bilayered Living Skin Construct. Surg Technol Int. 2000 Oct; IX:77-80. PMID: 12219282.
Falanga V. Classifications for wound bed preparation and stimulation of chronic wounds. Wound Repair Regen. 2000 Sep-Oct; 8(5):347-52. PMID: 11115147.
Gabel EA, Jimenez GP, Eaglstein WH, Kerdel FA, Falanga V. Performance comparison of nylon and an absorbable suture material (Polyglactin 910) in the closure of punch biopsy sites. Dermatol Surg. 2000 Aug; 26(8):750-2; discussion 752-3. PMID: 10940061.
Schonfeld WH, Villa KF, Fastenau JM, Mazonson PD, Falanga V. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers. Wound Repair Regen. 2000 Jul-Aug; 8(4):251-7. PMID: 11013015.
Falanga VJ. Tissue engineering in wound repair. Adv Skin Wound Care. 2000 May-Jun; 13(2 Suppl):15-9. PMID: 11074998.
Tokuda Y, Crane S, Yamaguchi Y, Zhou L, Falanga V. The levels and kinetics of oxygen tension detectable at the surface of human dermal fibroblast cultures. J Cell Physiol. 2000 Mar; 182(3):414-20. PMID: 10653608.
Nowak MA, Tsoukas MM, DeImus FA, Falanga V, Brodell RT. Generalized pruritus without primary lesions. Differential diagnosis and approach to treatment. Postgrad Med. 2000 Feb; 107(2):41-2, 45-6. PMID: 10689406.
Veves A, Falanga V. Diabetic Foot Ulcers: Prevention and Treatment. Wounds (Supplement). 2000.
Falanga V with Phillips T, Harding K, Moy R, Peerson L. Text Atlas of Wound Healing. Martin Dunitz Publishers. London. 2000.
Shen JT, Falanga V. Treatment of Venous Ulcers Using a Bilayered Living Skin Construct. Surgical Technology International IX. Editors Szabo Z, Lewis JE, Fantini GA, and Savalgi RS. Universal Medical Press. San Francisco. 2000; 77-80.
Shen JT, Falanga V. Treatment of venous ulcers using a bilayered living skin construct. Surg Technol Int. 2000; 9:77-80. PMID: 21136391.
Falanga V. Growth Factors. The Foot in Diabetes. John Wiley & Sons. UK. 2000; 169-178.
Falanga V. Scleroderma Update. Current Problems in Dermatology. Millenium Series. Editor Jeffery P. Callen. Mosby. St. Louis. 2000; 12(2):95-102.
Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999 Jul-Aug; 7(4):201-7. PMID: 10781211.
Falanga V, Fujitani RM, Diaz C, Hunter G, Jorizzo J, Lawrence PF, Lee BY, Menzoian JO, Tretbar LL, Holloway GA, Hoballah J, Seabrook GR, McMillan DE, Wolf W. Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebo-controlled trial. Wound Repair Regen. 1999 Jul-Aug; 7(4):208-13. PMID: 10781212.
Falanga V. Becaplermin: a viewpoint by vincent falanga. BioDrugs. 1999 May; 11(5):366-7. PMID: 18031146.
Kirsner RS, Kerdel FA, Falanga V, Trent J, Eaglstein WH. The role of mandated research during dermatology residency training. J Invest Dermatol. 1999 Mar; 112(3):400-1. PMID: 10084326.
Falanga V. Care of venous leg ulcers. Ostomy Wound Manage. 1999 Jan; 45(1A Suppl):33S-43S; quiz 44S-45S. PMID: 10085974.
Shen J, Falanga V. Bioengineered Skin and Treatment of Wounds: Use of an Epidermal-dermal Construct (Apligraf). Today's Therapeutic Trends. 1999; 17:197-205.
Romanelli M, Falanga V. Measurements of Transcutaneous Oxygen Tension in Chronic Wounds. Measurements in Wound Healing. Eds. Mani R, Shearman C, Sandeman D, Falanga V. WB Saunders Co., Ltd. New York. 1999; 68-80.
Falanga V . :Guest Editor for issue on Treatment of chronic wounds. Dermatologic Therapy. Munksgaard, Denmark. Vol. 9. 1999.
Measurements in Wound Healing. Mani R, Falanga V, Shearman C, Sandeman D (eds.). WB Saunders Co., Ltd. New York. 1999.
Falanga V. Treatment Strategies for Venous Leg Ulcers. Practical Vascular Surgery. Editors Yao JST and Pierce WH. Appleton & Lange. Stamford, CT. 1999; 507-515.
Falanga V. There is a new excitement these days in the way we view and treat chronic wounds. J Cutan Med Surg. 1998 Dec; 3 Suppl 1:before S1-1. PMID: 10328677.
Eaglstein WH, Falanga V. Tissue engineering for skin: an update. J Am Acad Dermatol. 1998 Dec; 39(6):1007-10. PMID: 9843017.
Falanga V, Greenberg AS, Zhou L, Ochoa SM, Roberts AB, Falabella A, Yamaguchi Y. Stimulation of collagen synthesis by the anabolic steroid stanozolol. J Invest Dermatol. 1998 Dec; 111(6):1193-7. PMID: 9856839.
Falanga V. Wound healing and chronic wounds. J Cutan Med Surg. 1998 Dec; 3 Suppl 1:S1-1-5. PMID: 10082600.
Falanga V. Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol. 1998 Dec; 25(12):812-7. PMID: 9990774.
Falabella AF, Carson P, Eaglstein WH, Falanga V. The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol. 1998 Nov; 39(5 Pt 1):737-40. PMID: 9810889.
Falabella A, Falanga V. Uncommon causes of ulcers. Clin Plast Surg. 1998 Jul; 25(3):467-79. PMID: 9696906.
Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf, a human skin equivalent. Cutis. 1998 Jul; 62(1 Suppl):1-8. PMID: 9787994.
Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf a human skin equivalent. Adv Wound Care. 1998 Jul-Aug; 11(4 Suppl):1-8. PMID: 10326339.
Ling MR, Swinyer LJ, Jarratt MT, Falo L, Monroe EW, Tharp M, Kalivas J, Weinstein GD, Asarch RG, Drake L, Martin AG, Leyden JJ, Cook J, Pariser DM, Pariser R, Thiers BH, Lebwohl MG, Babel D, Stewart DM, Eaglstein WH, Falanga V, Katz HI, Bergfeld WF, Hanifin JM, Young MR, et al. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol. 1998 Jun; 38(6 Pt 2):S95-102. PMID: 9631991.
Kirsner RS, Falanga V, Eaglstein WH. The development of bioengineered skin. Trends Biotechnol. 1998 Jun; 16(6):246-9. PMID: 9652135.
Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, Jensen J, Sabolinski M, Hardin-Young J. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol. 1998 Mar; 134(3):293-300. PMID: 9521027.
Weiss E, Yamaguchi Y, Falabella A, Crane S, Tokuda Y, Falanga V. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: correction with fibronectin and factor XIII cross-linking. J Cell Physiol. 1998 Jan; 174(1):58-65. PMID: 9397156.
Falanga V. Management of Venous Leg Ulcers. Expanding Techniques in Treating Chronic Wounds. Editor Camerota AJ. Excerpta Medica, Inc., Reed Elsevier Co. Belle Mead, NJ. 1998; 14-21.
Falabella A, Falanga V. Uncommon Causes of Ulcers. Clinics in Plastic Surgery. Wound Healing: State of the Art. Editors Granick MS, Long CD, Ramasastry SS. W.B. Saunders Co. Philadelphia. 1998; 467-479.
Falanga V, Gottlieb ME, Omlie WR. Management of commonly misdiagnosed chronic wounds. In Treatment of Chronic Wounds Series. Number 8. Curative Health Services, Inc. 1998.
Guest Editor, Vincent Falanga, MD, J Cut Med Surg. Wound healing and chronic wounds. In Wound Care Supplement. 1998; 3.
Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badiavas E, Falanga V. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci. 1997 Nov; 16(1):59-66. PMID: 9438909.
Van de Scheur M, Falanga V. Pericapillary fibrin cuffs in venous disease. A reappraisal. Dermatol Surg. 1997 Oct; 23(10):955-9. PMID: 9357508.
Tallman P, Muscare E, Carson P, Eaglstein WH, Falanga V. Initial rate of healing predicts complete healing of venous ulcers. Arch Dermatol. 1997 Oct; 133(10):1231-4. PMID: 9382561.
Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf, a human skin equivalent. Clin Ther. 1997 Sep-Oct; 19(5):894-905. PMID: 9385478.
Eaglstein WH, Falanga V. Chronic wounds. Surg Clin North Am. 1997 Jun; 77(3):689-700. PMID: 9194887.
LeBlanc N, Falabella A, Murata H, Hasan A, Weiss E, Falanga V. Durometer measurements of skin induration in venous disease. Dermatol Surg. 1997 Apr; 23(4):285-7. PMID: 9149796.
Murata H, Zhou L, Ochoa S, Hasan A, Badiavas E, Falanga V. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J Invest Dermatol. 1997 Mar; 108(3):258-62. PMID: 9036921.
Falanga V. Scleroderma. Skin Immune System (SIS). Editor Jan D. Bos. CRC Press LLC. 1997; 461-469.
Falanga V. Venous Ulceration. Chronic Wound Care: A Clinical Source Book for Health Care Professionals. Eds. Diane Krasner and Dean Kane. Health Management Publications, Inc. 1997; 165-171.
Kirsner RS, Spencer J, Falanga V, Garland LE, Kerdel FA. Squamous cell carcinoma arising in osteomyelitis and chronic wounds. Treatment with Mohs micrographic surgery vs amputation. Dermatol Surg. 1996 Dec; 22(12):1015-8. PMID: 9078313.
Bellman B, Reddy R, Falanga V. Generalized lichen planus associated with hepatitis C virus immunoreactivity. J Am Acad Dermatol. 1996 Nov; 35(5 Pt 1):770-2. PMID: 8912576.
Badiavas E, Mehta PP, Falanga V. Retrovirally mediated gene transfer in a skin equivalent model of chronic wounds. J Dermatol Sci. 1996 Oct; 13(1):56-62. PMID: 8902654.
Greenberg AS, Hasan A, Montalvo BM, Falabella A, Falanga V. Acute lipodermatosclerosis is associated with venous insufficiency. J Am Acad Dermatol. 1996 Oct; 35(4):566-8. PMID: 8859285.
Falanga V. Iodine-containing Pharmaceuticals: A Reappraisal. Proceedings of the 6th European Conference on Advances in Wound Management. Macmillan Magazines Ltd. London. 1996.
Kirsner RS, Falanga V, Kerdel FA, Katz MH, Eaglstein WH. Skin grafts as pharmacological agents: pre-wounding of the donor site. Br J Dermatol. 1996 Aug; 135(2):292-6. PMID: 8881677.
Greenberg AS, Takagi H, Hill RH, Hasan A, Murata H, Falanga V. Delayed onset of skin fibrosis after the ingestion of eosinophilia-myalgia syndrome-associated L-tryptophan. J Am Acad Dermatol. 1996 Aug; 35(2 Pt 1):264-6. PMID: 8708033.
Falanga V, Carson P, Greenberg A, Hasan A, Nichols E, McPherson J. Topically applied recombinant tissue plasminogen activator for the treatment of venous ulcers. Preliminary report. Dermatol Surg. 1996 Jul; 22(7):643-4. PMID: 8680787.
Cai JP, Falanga V, Taylor JR, Chin YH. Transforming growth factor-beta receptor binding and function are decreased in psoriatic dermal endothelium. J Invest Dermatol. 1996 Feb; 106(2):225-31. PMID: 8601720.
Cai JP, Harris K, Falanga V, Taylor JR, Chin YH. UVB therapy decreases the adhesive interaction between peripheral blood mononuclear cells and dermal microvascular endothelium, and regulates the differential expression of CD54, VCAM-1, and E-selectin in psoriatic plaques. Br J Dermatol. 1996 Jan; 134(1):7-16. PMID: 8745879.
Falanga V. Scleroderma Syndromes. Principles and Practice of Dermatology. W. Mitchell Sams, Jr. and Peter J. Lynch, editors. Churchill Livingstone. New York. 1996; 607-617.
Greenberg SA, Falanga V. Localized Cutaneous Sclerosis. Cutaneous Manifestations of Rheumatic Diseases. Eds. Sontheimer RD, Provost TT. Williams & Wilkins. Philadelphia. 1996; 141-155.
Bellman B, Reddy RK, Falanga V. Lichen planus associated with hepatitis C. Lancet. 1995 Nov 4; 346(8984):1234. PMID: 7475692.
Takagi H, Ochoa MS, Zhou L, Helfman T, Murata H, Falanga V. Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic. J Clin Invest. 1995 Nov; 96(5):2120-5. PMID: 7593596; PMCID: PMC185860.
Laszlo KS, Falanga V, Kerdel FA. Idiopathic palmar fasciitis. Int J Dermatol. 1995 Sep; 34(9):658-60. PMID: 7591472.
Helfman T, Falanga V. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol. 1995 Aug; 33(2 Pt 1):254-8. PMID: 7622653.
Kirsner RS, Mata SM, Falanga V, Kerdel FA. Split-thickness skin grafting of leg ulcers. The University of Miami Department of Dermatology's experience (1990-1993). Dermatol Surg. 1995 Aug; 21(8):701-3. PMID: 7633815.
Falanga V, Zhou LH, Takagi H, Murata H, Ochoa S, Martin TA, Helfman T. Human dermal fibroblast clones derived from single cells are heterogeneous in the production of mRNAs for alpha 1(I) procollagen and transforming growth factor-beta 1. J Invest Dermatol. 1995 Jul; 105(1):27-31. PMID: 7615971.
Falanga V, Grinnel F, Gilchrest B, Maddox YT, Moshell A. Experimental approaches to chronic wounds. Wound Repair Regen. 1995 Apr-Jun; 3(2):132-40.View Related Profiles.
Romanelli M, Falanga V. Use of a durometer to measure the degree of skin induration in lipodermatosclerosis. J Am Acad Dermatol. 1995 Feb; 32(2 Pt 1):188-91. PMID: 7829701.
Higley HR, Ksander GA, Gerhardt CO, Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol. 1995 Jan; 132(1):79-85. PMID: 7538779.
Pardes JB, Takagi H, Martin TA, Ochoa MS, Falanga V. Decreased levels of alpha 1(I) procollagen mRNA in dermal fibroblasts grown on fibrin gels and in response to fibrinopeptide B. J Cell Physiol. 1995 Jan; 162(1):9-14. PMID: 7814454.
Falanga V, Eaglstein WH. Leg and foot ulcers: A clinician's guide. Martin Dunitz publisher, London. 1995; 182 pages.
Pardes J, Falanga V. Leg Ulcers. Current Practice of Medicine. Ed. Roger C. Bone. Dermatology Section Ed. Callen J. Current Medicine. Philadelphia. 1995; 87-95.
Falanga V. Scleroderma, Raynaud's Phenomenon, and Related Conditions. Dermatologic Signs of Internal Disease. Ed. Callen J et al. W.B. Saunders Company. Philadelphia. 1995; 21-30.
Falanga V, Schachner LA, Rae V, Ceballos PI, Gonzalez A, Liang G, Banks R. Dermatologic consultations in the hospital setting. Arch Dermatol. 1994 Aug; 130(8):1022-5. PMID: 8053699.
Helfman T, Falanga V. Eosinophilic fasciitis. Clin Dermatol. 1994 Jul-Sep; 12(3):449-55. PMID: 7954202.
Falanga V, Takagi H, Ceballos PI, Pardes JB. Low oxygen tension decreases receptor binding of peptide growth factors in dermal fibroblast cultures. Exp Cell Res. 1994 Jul; 213(1):80-4. PMID: 8020609.
Basso A, Pardes J, Helfman T, Peerson LJ, Falanga V. Adaptation of a pressure relief dressing for the treatment of leg ulcers. J Am Acad Dermatol. 1994 May; 30(5 Pt 1):779-80. PMID: 8176019.
Helfman T, Ovington L, Falanga V. Occlusive dressings and wound healing. Clin Dermatol. 1994 Jan-Mar; 12(1):121-7. PMID: 8180934.
Falanga V, Grinnell F, Gilchrest B, Maddox YT, Moshell A. Workshop on the pathogenesis of chronic wounds. J Invest Dermatol. 1994 Jan; 102(1):125-7.View Related Profiles.
Helfman T, Ovington L, Falanga V. Occlusive Dressings and Wound Healing. Clinics of Dermatology. Ed. Eric F. Bernstein. Elsevier. 1994; 12(1):121-127.
Helfman T, Falanga V. Eosinophilic Fasciitis. Clinics in Dermatology. Scleroderma: From Morphea to Systemic Sclerosis. Eds. Lotti T, Matucci-Cerinic M. 1994; 12:449-455.
Pardes JB, Falanga V, Kerdel FA. Delayed cutaneous ulcerations arising at sites of prior parenteral drug abuse. J Am Acad Dermatol. 1993 Dec; 29(6):1052-4. PMID: 8245248.
Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes J, Ochoa MS. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol. 1993 Nov; 157(2):408-12. PMID: 8227170.
Falanga V. Growth factors and wound healing. Dermatol Clin. 1993 Oct; 11(4):667-75. PMID: 8222350.
Pardes JB, Carson PA, Eaglstein WH, Falanga V. Mupirocin treatment of exudative venous ulcers. J Am Acad Dermatol. 1993 Sep; 29(3):497-8.View Related Profiles.
Falanga V. Wound healing. An overview. J Dermatol Surg Oncol. 1993 Aug; 19(8):689-90. PMID: 8349908.
Falanga V. Growth factors and wound healing. J Dermatol Surg Oncol. 1993 Aug; 19(8):711-4. PMID: 8349910.
Falanga V. Venous ulceration. J Dermatol Surg Oncol. 1993 Aug; 19(8):764-71. PMID: 8349918.
Kirsner RS, Falanga V. Techniques of split-thickness skin grafting for lower extremity ulcerations. J Dermatol Surg Oncol. 1993 Aug; 19(8):779-83. PMID: 7794287.
Falanga V, Bucalo B. Use of a durometer to assess skin hardness. J Am Acad Dermatol. 1993 Jul; 29(1):47-51. PMID: 8315077.
Helfman T, Falanga V. Gene expression in low oxygen tension. Am J Med Sci. 1993 Jul; 306(1):37-41. PMID: 8328508.
Bucalo B, Eaglstein WH, Falanga V. Inhibition of cell proliferation by chronic wound fluid. Wound Repair Regen. 1993 Jul; 1(3):181-6. PMID: 17163887.
Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol. 1993 May; 100(5):721-5. PMID: 8491995.
Falanga V, Eaglstein WH. The "trap" hypothesis of venous ulceration. Lancet. 1993 Apr 17; 341(8851):1006-8. PMID: 7682272.
Kirsner RS, Goodless D, Kerdel FA, Pardes JB, Falanga V. Enlargement of the hands and feet in a chronic smoker. Arthritis Rheum. 1993 Apr; 36(4):569-71. PMID: 8457231.
Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol. 1993 Apr; 28(4):623-7. PMID: 8463465.
Kirsner RS, Falanga V, Eaglstein WH. The biology of skin grafts. Skin grafts as pharmacologic agents. Arch Dermatol. 1993 Apr; 129(4):481-3. PMID: 8466221.
Falanga V, Kirsner RS. Low oxygen stimulates proliferation of fibroblasts seeded as single cells. J Cell Physiol. 1993 Mar; 154(3):506-10. PMID: 8436599.
Harris B, Eaglstein WH, Falanga V. Basal cell carcinoma arising in venous ulcers and mimicking granulation tissue. J Dermatol Surg Oncol. 1993 Feb; 19(2):150-2. PMID: 8429142.
Falanga V. The "wrinkle test": clinical use for detecting early epidermal resurfacing. J Dermatol Surg Oncol. 1993 Feb; 19(2):172-3. PMID: 8429148.
Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA, Falanga V. Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia. J Am Acad Dermatol. 1993 Jan; 28(1):71-4. PMID: 8425973.
Kirsner RS, Pardes JB, Falanga V. Solitary fibrosing paraspinal plaque: solitary morphoea profunda? Br J Dermatol. 1993 Jan; 128(1):99-101. PMID: 8427830.
Falanga V. Growth Factors and Wound Healing. New Trends in Dermatologic Surgery. Eds. Roegnik RK, Roegnik HH. Martin Dunitz. London. 1993; 47-54.
Falanga V. Special Issue on Wound Healing: An Overview. Practical Aspects of Wound Healing, ed. Falanga V. Special issue of the J Dermatol Surg Oncol. 1993; 19.
Growth Factors in Wound Healing and Fibrosis. Dermatology. Progress and Perspectives. Eds. Burgdorf WHC and Katz SI. The Parthenon Publishing Group LTD. New York. 1993; 421-426.
Falanga V (ed.). Practical Aspects of Wound Healing. Special issue of the J Dermatol Surg Oncol. 1993; 19.
Falanga V. Growth Factors and Wound Healing. Dermatologic Clinics. Ed. Nemeth AJ. W.B. Saunders Company. 1993; 11:667-675.
Falanga V, Katz MH, Kirsner R, Alvarez AF. The effects of endothelin-1 on human dermal fibroblast growth and synthetic activity. J Surg Res. 1992 Nov; 53(5):515-9. PMID: 1434602.
Falanga V. Growth factors and chronic wounds: the need to understand the microenvironment. J Dermatol. 1992 Nov; 19(11):667-72. PMID: 1293152.
Kirsner RS, Falanga V. Features of an autoimmune process in mid-dermal elastolysis. J Am Acad Dermatol. 1992 Nov; 27(5 Pt 2):832-4. PMID: 1469138.
Falanga V, Eaglstein WH, Bucalo B, Katz MH, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol. 1992 Jul; 18(7):604-6. PMID: 1624634.
Falanga V, Gerhardt CO, Dasch JR, Takehara K, Ksander GA. Skin distribution and differential expression of transforming growth factor beta 1 and beta 2. J Dermatol Sci. 1992 May; 3(3):131-6. PMID: 1498091.
Falanga V, Kirsner R, Katz MH, Gould E, Eaglstein WH, McFalls S. Pericapillary fibrin cuffs in venous ulceration. Persistence with treatment and during ulcer healing. J Dermatol Surg Oncol. 1992 May; 18(5):409-14. PMID: 1607464.
Cai JP, Falanga V, Taylor JR, Chin YH. Transforming growth factor-beta differentially regulates the adhesiveness of normal and psoriatic dermal microvascular endothelial cells for peripheral blood mononuclear cells. J Invest Dermatol. 1992 Apr; 98(4):405-9. PMID: 1548425.
Harris B, Cai JP, Falanga V, Mertz P, Chin YH, Eaglstein W. The effects of occlusive dressings on the recruitment of mononuclear cells by endothelial binding into acute wounds. J Dermatol Surg Oncol. 1992 Apr; 18(4):279-83. PMID: 1560151.
Falanga V. Transforming Growth Factor-Beta (TGF-Beta): The Potential for Fibrosis and the Realities. Scleroderma International Symposium - Current Topics in Scleroderma. Eds. Maeda M and Ogawa I. Seino Printing Company, Ltd. Gifu City, Japan. 1992; 171-179.
Rothe MJ, Falanga V. Growth Factors and Wound Healing. Clinics in Dermatology. 1992; 9:553-559.
Falanga V. Chronic Wounds: Pathophysiologic and Experimental Considerations. Progress in Dermatology. 1992; 26(4):1992.
Katz MH, Alvarez AF, Kirsner RS, Eaglstein WH, Falanga V. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol. 1991 Dec; 25(6 Pt 1):1054-8. PMID: 1810982.
Falanga V, Kruskal JB, Franks JJ. Fibrin and fibrinogen-related antigens in systemic sclerosis (scleroderma) J Am Acad Dermatol. 1991 Nov; 25(5 Pt 1):771-5. PMID: 1802898.
Nemeth AJ, Eaglstein WH, Taylor JR, Peerson LJ, Falanga V. Faster healing and less pain in skin biopsy sites treated with an occlusive dressing. Arch Dermatol. 1991 Nov; 127(11):1679-83. PMID: 1952972.
Rothe MJ, Falanga V. Growth factors and wound healing. Clin Dermatol. 1991 Oct-Dec; 9(4):553-9. PMID: 1822411.
Falanga V, Qian SW, Danielpour D, Katz MH, Roberts AB, Sporn MB. Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J Invest Dermatol. 1991 Oct; 97(4):634-7. PMID: 1940433.
Falanga V, Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet. 1991 Aug 10; 338(8763):347-8. PMID: 1677702.
Blauvelt A, Falanga V. Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination. Arch Dermatol. 1991 Aug; 127(8):1159-66. PMID: 1863073.
Cai JP, Falanga V, Chin YH. Transforming growth factor-beta regulates the adhesive interactions between mononuclear cells and microvascular endothelium. J Invest Dermatol. 1991 Aug; 97(2):169-74. PMID: 2071932.
Falanga V, Katz MH, Goodless DR. Proliferation and collagen synthesis by human dermal fibroblasts cultured from different body sites. J Dermatol Sci. 1991 May; 2(3):166-70. PMID: 1878345.
Romanelli M, Katz MH, Alvarez AF, Eaglstein WH, Falanga V. The effect of topical nitroglycerin on transcutaneous oxygen. Br J Dermatol. 1991 Apr; 124(4):354-7. PMID: 1902742.
Falanga V, McKenzie A, Eaglstein WH. Heterogeneity in oxygen diffusion around venous ulcers. J Dermatol Surg Oncol. 1991 Apr; 17(4):336-9. PMID: 2040746.
Falanga V. Fibrosing conditions in childhood. Adv Dermatol. 1991; 6:145-58; discussion 159. PMID: 1983952.
Falanga V, Kruskal J, Franks JJ. Fibrin- and fibrinogen-related antigens in patients with venous disease and venous ulceration. Arch Dermatol. 1991 Jan; 127(1):75-8. PMID: 1986710.
Falanga V, Katz MH. Clinical spectrum of venous disease. Prog Clin Biol Res. 1991; 365:19-25. PMID: 1862131.
Cai JP, Harris B, Falanga V, Eaglstein WH, Mertz PM, Chin YH. Recruitment of mononuclear cells into wounded skin: mechanism and modulation. Prog Clin Biol Res. 1991; 365:243-56. PMID: 1862136.
Eaglstein WH, Mertz PM, Falanga V. Wound dressings: current and future. Prog Clin Biol Res. 1991; 365:257-65. PMID: 1862137.
Nemeth AJ, Eaglstein WH, Falanga V, Hevia O, Taylor JR. Methods to speed healing after skin biopsy or trichloroacetic acid chemical peel. Prog Clin Biol Res. 1991; 365:267-77. PMID: 1862138.
Nemeth AJ, Eaglstein WH, Falanga V, Hevia O, Taylor RJ. Methods to Speed Healing after Skin Biopsy or Trichloroacetic Acid Chemical Peel. Clinical and Experimental Approach to Dermal and Epidermal Repair. Eds. Barbul A, Caldwell MD, Eaglstein WH, Hunt TK, Marshall D, Pines E, Skover G. Wiley-Liss. New York. 1991; 267-277.
Falanga V, Katz MH. Clinical Spectrum of Venous Disease. Clinical and Experimental Approaches to Dermal and Epidermal Repair. Eds Barbul A, Caldwell MD, Eaglstein WH, Hunt TK, Marshall D, Pines E, Skover G. Wiley-Liss. New York. 1991; 19-25.
Katz MH, Falanga V, Eaglstein WH. Leg Ulcers: A Wound Healing Model. Recent Advances in Dermatology, eds. Champion RH and Pye RJ. Churchill Livingstone. New York. 1991; 9:199-218.
Falanga V. Growth Factors: Status and Expectations. International Symposium on Wound Management. Ed. Leaper DJ. Medicom Europe. The Netherlands. 1991; 87-93.
Falanga V. Fibrosing Syndromes of Childhood. Advancs in Dermatology. Mosby Year Book. St. Louis, MO. 1991; 6:145-159.
Chin YH, Falanga V, Cai JP. Lymphocyte adhesion to psoriatic dermal endothelium: mechanism and modulation. J Invest Dermatol. 1990 Nov; 95(5):29S-31S. PMID: 2230204.
Chin YH, Falanga V, Cai JP. Lymphocyte adhesion to psoriatic dermal endothelium: mechanism and modulation. J Invest Dermatol. 1990 Nov; 95(5 Suppl):29S-31S. PMID: 16788626.
Cai JP, Harris B, Falanga V, Eaglstein WH, Mertz PM, Chin YH. Recruitment of mononuclear cells by endothelial cell binding into wounded skin is a selective, time-dependent process with defined molecular interactions. J Invest Dermatol. 1990 Oct; 95(4):415-21. PMID: 2212726.
Falanga V, Bontempo FA, Eaglstein WH. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol. 1990 Sep; 126(9):1195-7. PMID: 2144413.
Falanga V, Iriondo M. Zinc chloride paste for the debridement of chronic leg ulcers. J Dermatol Surg Oncol. 1990 Jul; 16(7):658-61. PMID: 2362028.
Falanga V, Medsger TA. D-penicillamine in the treatment of localized scleroderma. Arch Dermatol. 1990 May; 126(5):609-12. PMID: 2334179.
Pathy AL, Rae V, Falanga V. Subcutaneous calcification in venous ulcers: report of a case. J Dermatol Surg Oncol. 1990 May; 16(5):450-2. PMID: 2341659.
Chin YH, Falanga V, Taylor JR, Cai JP, Bax J. Adherence of human helper/memory T-cell subsets to psoriatic dermal endothelium. J Invest Dermatol. 1990 Apr; 94(4):413-7. PMID: 1968932.
Falanga V, Soter NA, Altman RD, Kerdel FA. Elevated plasma histamine levels in systemic sclerosis (scleroderma). Arch Dermatol. 1990 Mar; 126(3):336-8. PMID: 2310207.
Falanga V, Julien JM. Observations in the potential role of transforming growth factor-beta in cutaneous fibrosis. Systemic sclerosis. Ann N Y Acad Sci. 1990; 593:161-71. PMID: 2165374.
Falanga V. Scleroderma Syndromes. Textbook of Dermatology. Mitchell Sams, P. Lynch, eds. Churchill Livingstone Inc. New York. 1990; 589-599.
Weiss DS, Eaglstein WH, Falanga V. Exogenous electric current can reduce the formation of hypertrophic scars. J Dermatol Surg Oncol. 1989 Dec; 15(12):1272-5. PMID: 2592666.
Rothe M, Falanga V. Growth factors. Their biology and promise in dermatologic diseases and tissue repair. Arch Dermatol. 1989 Oct; 125(10):1390-8. PMID: 2679401.
Liang G, Pardo RJ, Voigt W, Gould EW, Falanga V. Studies of immunoglobulin and T cell receptor gene rearrangement in cutaneous B and T cell lymphomas. J Am Acad Dermatol. 1989 Sep; 21(3 Pt 1):457-60. PMID: 2789234.
Falanga V. Localized scleroderma. Med Clin North Am. 1989 Sep; 73(5):1143-56. PMID: 2671537.
Chin YH, Falanga V, Streilein JW, Sackstein R. Lymphocyte recognition of psoriatic endothelium: evidence for a tissue-specific receptor/ligand interaction. J Invest Dermatol. 1989 Aug; 93(2 Suppl):82S-87S. PMID: 2546996.
Rae V, Falanga V. Wrinkling due to middermal elastolysis. Report of a case and review of the literature. Arch Dermatol. 1989 Jul; 125(7):950-1. PMID: 2525896.
Falanga V, Soter NA, Kerdel FA. Increased plasma histamine level in eosinophilic fasciitis. Arch Dermatol. 1989 Jun; 125(6):805-8. PMID: 2730101.
Rae V, Pardo RJ, Blackwelder PL, Falanga V. Leg ulcers following subcutaneous injection of a liquid silicone preparation. Arch Dermatol. 1989 May; 125(5):670-3. PMID: 2712585.
Aly R, Maibach HI, Bagatell FK, Dittmar W, Hänel H, Falanga V, Leyden JJ, Roth HL, Stoughton RB, Willis I, et al. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis. Clin Ther. 1989 May-Jun; 11(3):290-303. PMID: 2663159.
Nemeth AJ, Eaglstein WH, Falanga V. Clinical parameters and transcutaneous oxygen measurements for the prognosis of venous ulcers. J Am Acad Dermatol. 1989 Feb; 20(2 Pt 1):186-90. PMID: 2915052.
Nemeth AJ, Falanga V, Alstadt SP, Eaglstein WH. Ulcerated edematous limbs: effect of edema removal on transcutaneous oxygen measurements. J Am Acad Dermatol. 1989 Feb; 20(2 Pt 1):191-7. PMID: 2915053.
Falanga V. Venous Ulcers and Other Cutaneous Ulcerations. Conn's Current Therapy. Robert E. Rakel, ed. W.B. Saunders Co. Philadelphia. 1989; 743-747.
Falanga V, Eaglstein WH. Practical Management of Leg Ulcers in the Elderly. Geriatric Dermatology: Clinical Diagnosis and Practical Therapy. Victor D. Newcomer, Edward M. Young, eds. Igaku-Shoin. New York. 1989; 503-510.
Falanga V. Localized Scleroderma. Collagen Vascular Diseases. Medical Clinics of North America. Callen JP, (ed). W.B. Saunders Co. Philadelphia. 1989; 73(5):1143-1156.
Rothe MJ, Altman RD, Falanga V. Plasma somatomedin-C levels in systemic sclerosis. Br J Dermatol. 1988 Nov; 119(5):639-42. PMID: 3207616.
Sackstein R, Falanga V, Streilein JW, Chin YH. Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction. J Invest Dermatol. 1988 Nov; 91(5):423-8. PMID: 3262692.
Silverstein JL, Steen VD, Medsger TA, Falanga V. Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). Arch Dermatol. 1988 Sep; 124(9):1379-82. PMID: 3415281.
Falanga V, Zitelli JA, Eaglstein WH. Wound healing. J Am Acad Dermatol. 1988 Sep; 19(3):559-63. PMID: 3170815.
Chin YH, Falanga V, Streilein JW, Sackstein R. Specific lymphocyte-endothelial cell interactions regulate migration into lymph nodes, Peyer's patches, and skin. Reg Immunol. 1988 Jul-Aug; 1(1):78-83. PMID: 3079311.
Falanga V. Occlusive wound dressings. Why, when, which? Arch Dermatol. 1988 Jun; 124(6):872-7. PMID: 3288123.
Falanga V, Alstadt SP. Effect of a platelet release fraction on glycosaminoglycan synthesis by cultured dermal fibroblasts from patients with progressive systemic sclerosis. Br J Dermatol. 1988 Mar; 118(3):339-45. PMID: 3355777.
Falanga V. Venous Ulcers and Other Cutaneous Ulcerations. Conn's Current Therapy. Robert E. Rakel, ed. W.B. Saunders Company. Philadelphia. 1988; 719-722.
Falanga V, Eaglstein WH. Wound Healing: Practical Aspects. Progress in Dermatology. 1988; 22:1-10.
Eaglstein WH, Falanga V, Nemeth A, Moosa H. Pericapillary fibrin, venous ulcers, and transcutaneous oxygen. Fibrinolysis and angiogenesis in wound healing. Cederholm-Williams SA, Ryan TJ, Lydon MJ, editors. Excerpta Medica, Elsevier Co. Princeton, NJ. 1988; 12-15.
Falanga V, Medsger TA. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol. 1987 Oct; 17(4):648-56. PMID: 3668010.
Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology. 1987 Oct; 38(10):769-84. PMID: 3310742.
Falanga V, Tiegs SL, Alstadt SP, Roberts AB, Sporn MB. Transforming growth factor-beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol. 1987 Jul; 89(1):100-4. PMID: 3496398.
Moosa HH, Falanga V, Steed DL, Makaroun MS, Peitzman AB, Eaglstein WH, Webster MW. Oxygen diffusion in chronic venous ulceration. J Cardiovasc Surg (Torino). 1987 Jul-Aug; 28(4):464-7. PMID: 3597541.
Falanga V, Moosa HH, Nemeth AJ, Alstadt SP, Eaglstein WH. Dermal pericapillary fibrin in venous disease and venous ulceration. Arch Dermatol. 1987 May; 123(5):620-3. PMID: 3555351.
Falanga V, Medsger TA, Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol. 1987 Mar; 123(3):350-3. PMID: 3545090.
Eaglstein WH, Mertz PM, Falanga V. Occlusive dressings. Am Fam Physician. 1987 Mar; 35(3):211-6. PMID: 3825848.
Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol. 1986 Oct; 122(10):1194-8. PMID: 3767406.
Falanga V, Medsger TA, Reichlin M, Rodnan GP. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med. 1986 Jun; 104(6):849-57. PMID: 3486617.
Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986 Jun; 83(12):4167-71. PMID: 2424019; PMCID: PMC323692.
Falanga V, Eaglstein WH. A therapeutic approach to venous ulcers. J Am Acad Dermatol. 1986 May; 14(5 Pt 1):777-84. PMID: 3519695.
Falanga V, Eaglstein WH. Management of venous ulcers. Am Fam Physician. 1986 Feb; 33(2):274-81. PMID: 2936224.
Falanga V. Infantile acropustulosis with eosinophilia. J Am Acad Dermatol. 1985 Nov; 13(5 Pt 1):826-8. PMID: 4078080.
Falanga V, Campbell DE, Leyden JJ, Douglas SD. Nasal carriage of Staphylococcus aureus and antistaphylococcal immunoglobulin E antibodies in atopic dermatitis. J Clin Microbiol. 1985 Sep; 22(3):452-4. PMID: 4044803; PMCID: PMC268433.
Falanga V, Hebda PA, Eaglstein WH. Effect of platelet homogenate on in vitro glycosaminoglycans production by dermal fibroblasts from systemic sclerosis patients and normal controls. Br J Dermatol. 1985 Aug; 113(2):237-43. PMID: 4027190.
Falanga V, Medsger TA, Reichlin M. High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol. 1985 Mar; 121(3):345-7. PMID: 3883904.
Falanga V, Kapoor W. Cerebral cysticercosis: diagnostic value of subcutaneous nodules. Report of two cases. J Am Acad Dermatol. 1985 Feb; 12(2 Pt 1):304-7. PMID: 3973125.
Check JH, Gentlesk MJ, Falanga V. Sympathomimetic amines in the treatment of chronic urticaria: two case reports. Cutis. 1984 Oct; 34(4):388-90. PMID: 6488891.
Falanga V, Zheng P, Lavker RM. Ultrastructural study of iron deposition in the eccrine sweat glands of patients with iron overload. Br J Dermatol. 1984 Jan; 110(1):51-6. PMID: 6691917.
Caralis PV, Falanga V, Pardo V. Delayed form of Wegener's granulomatosis. South Med J. 1981 Jul; 74(7):882-3. PMID: 7256338.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.